Attendo AB (publ) (STO: ATT)
Sweden
· Delayed Price · Currency is SEK 48.10
+0.05 (0.10%)
Aug 30, 2024, 5:29 PM CET
Attendo AB Revenue
Attendo AB had revenue of 4.84B SEK in the quarter ending June 30, 2024, with 11.72% growth. This brings the company's revenue in the last twelve months to 18.14B, up 14.47% year-over-year. In the year 2023, Attendo AB had annual revenue of 17.29B with 19.25% growth.
Revenue (ttm)
18.14B
Revenue Growth
+14.47%
P/S Ratio
0.42
Revenue / Employee
518.20K
Employees
31,000
Market Cap
7.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 17.29B | 2.79B | 19.25% |
| Dec 31, 2022 | 14.50B | 1.63B | 12.66% |
| Dec 31, 2021 | 12.87B | 579.00M | 4.71% |
| Dec 31, 2020 | 12.29B | 353.00M | 2.96% |
| Dec 31, 2019 | 11.94B | 948.00M | 8.63% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.04B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |